[精品课件]化疗相关性呕吐治疗进展.pptVIP

* 根据药物作用的手提，可以将 * During the acute, delayed, and overall time intervals, significantly more patients treated with palonosetron 0.25 mg achieved a CR compared with those treated with ondansetron (p0.025; 97.5% CI of the difference does not include zero). During these time intervals, CR rates were numerically higher, but not statistically different, for palonosetron 0.75 mg compared with ondansetron. 1. Gralla R et al. Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial co